Edition:
United States

Basilea Pharmaceutica AG (BSLN.S)

BSLN.S on Swiss Exchange

68.45CHF
3:56am EST
Change (% chg)

CHF-0.25 (-0.36%)
Prev Close
CHF68.70
Open
CHF68.85
Day's High
CHF69.05
Day's Low
CHF68.30
Volume
11,971
Avg. Vol
66,573
52-wk High
CHF95.35
52-wk Low
CHF66.90

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 2 91.25 98.10 84.40 109.85
Earnings (per share)
Year Ending Dec-18 1 -2.59 -2.59 -2.59 -1.50
Sales and Profit Figures in Swiss Franc (CHF);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 189.80 34.75
P/E High - Last 5 Yrs. -- 284.12 46.00
P/E Low - Last 5 Yrs. -- 92.89 24.22
Beta 1.37 0.81 0.81
Price to Sales (TTM) 10.66 135.24 8.23
Price to Book (MRQ) -- 20.37 5.26
Price to Tangible Book (MRQ) -- 28.60 6.43
Price to Cash Flow (TTM) -- 126.27 26.16
% Owned Institutions -- 11.97 2.26

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.51
Dividend Yield - 5 Year Avg 1.21 0.20 2.02
Dividend 5 Year Growth Rate -- 1.92 5.22
Payout Ratio(TTM) -- 8.39 43.43

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 38.49 63.69 9.79
Sales (TTM) vs TTM 1 Yr. Ago 35.14 63.80 7.60
Sales - 5 Yr. Growth Rate -0.50 33.26 10.22
EPS (MRQ) vs Qtr. 1 Yr. Ago 31.18 -99.96 17.74
EPS (TTM) vs TTM 1 Yr. Ago 28.13 -- --
EPS - 5 Yr. Growth Rate -- 46.90 11.61
Capital Spending - 5 Yr. Growth Rate -34.31 42.29 14.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.78 1.68 2.43
Current Ratio (MRQ) 2.98 5.76 3.39
LT Debt to Equity (MRQ) -- 16.49 12.05
Total Debt to Equity (MRQ) -- 18.61 15.44
Interest Coverage (TTM) -17.38 -166.79 38.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 92.31 46.28 54.71
Gross Margin - 5 Yr. Avg. -- 55.52 52.58
EBITD Margin (TTM) -45.22 -- --
EBITD - 5 Yr. Avg -84.28 -236.98 14.67
Operating Margin (TTM) -48.03 -474.87 4.61
Operating Margin - 5 Yr. Avg. -89.66 -253.74 9.99
Pre-Tax Margin (TTM) -56.97 -449.94 5.35
Pre-Tax Margin - 5 Yr. Avg. -92.75 -260.30 10.27
Net Profit Margin (TTM) -57.44 -445.34 1.86
Net Profit Margin - 5 Yr. Avg. -93.21 -263.73 6.57
Effective Tax Rate (TTM) -- 0.42 21.98
Effective Tax Rate - 5 Yr. Avg. -- 18.01 24.18

Efficiency

  Company industry sector
Revenue/Employee (TTM) 318,667 23,891,213 828,235,197
Net Income/Employee (TTM) -183,042 -630,600 96,880,046
Receivable Turnover (TTM) 27.34 14.32 5.42
Inventory Turnover (TTM) 0.45 2.43 3.50
Asset Turnover (TTM) 0.24 0.39 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -13.74 -1.01 10.70
Return on Assets - 5 Yr. Avg. -14.90 -0.24 12.05
Return on Investment (TTM) -17.70 -0.65 13.63
Return on Investment - 5 Yr. Avg. -18.35 2.39 15.78
Return on Equity (TTM) -- -3.21 15.25
Return on Equity - 5 Yr. Avg. -78.01 -1.55 17.01
  1 Year 3 Year 5 Year
Sales % 25.91 16.67 -0.50
EPS (TTM) % 16.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Basilea Pharmaceutica AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -14.02 -8.68 95 55
13 Week -10.62 -7.61 99 93
26 Week -14.13 -14.42 99 88
52 Week -16.87 -20.77 99 88
YTD -10.74 -6.84 99 91
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 31.21%
# of Holders: 79
Total Shares Held: 3,705,624
3 Mo. Net Change: -349,253
# New Positions: 0
# Closed Positions: 3
# Increased Positions: 14
# Reduced Positions: 16
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.